STD Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments and Devices, Consumables, and Software); By Application; Technology; By Region; Segment Forecast, 2024 - 2032
- Published Date:Feb-2024
- Pages: 118
- Format: PDF
- Report ID: PM4507
- Base Year: 2023
- Historical Data: 2019 – 2022
Report Outlook
STD diagnostics market size was valued at USD 10.06 billion in 2023. The market is anticipated to grow from USD 10.81 billion in 2024 to USD 19.63 billion by 2032, exhibiting the CAGR of 7.7% during the forecast period.
Market Overview
Rapid increase in the burden of STDs (sexually transmitted diseases) globally and surge in the number of favorable government initiatives and efforts promoting the early detection of such diseases, are key factors influencing market’s growth. Additionally, rising awareness among general public and healthcare professionals regarding the importance of early detection of STDs for effective treatment, also leading to greater need for efficient diagnostic tests.
- For instance, in July 2023, The World Health Organization, released its latest guidance to improve the diagnosis and treatment of sexually transmitted infections. As over 1 million new STIs (sexually transmitted infections) are acquired on daily basis, that creates a global challenge for the treatment or diagnosis of such infections.
As more number of innovated tools are increasingly need worldwide to fight against the STDs because there are no signs of slowing the number of STDs without long-term investment and new game-changing innovations in rapid diagnostics, vaccine development, prevention, and treatment. Thus, companies are heavily focusing on the development of new solutions for efficient care or diagnosis of STIs.
To Understand More About this Research: Request a Free Sample Report
- For instance, in May 2022, Becton, Dickinson, and Company, announced the launch of its new automated and high-throughput infectious disease molecular diagnostic platform. The newly developed system includes a single test which detects three most prevalent non-viral sexually transmitted infection.
The STD Diagnostics Market report details key market dynamics to help industry players align their business strategies with current and future trends. It examines technological advances and breakthroughs in the industry and their impact on the market presence. Furthermore, a detailed regional analysis of the industry at the local, national, and global levels has been provided.
Market Trends
Growth Factors
Increasing incidences of STDs worldwide to drive market’s growth
The number of people suffering with several types of sexually transmitted diseases in increasing rapidly across the globe, which acts as a significant driver for the market. Also, growing awareness, changes in sexual behaviors, and higher screening are also the factors contribute to the diagnosis of STDs globally.
- For instance, according to the World Health Organization, every year more than 374 million new STI infections are acquired across the world. And, over 500 million aged 15049 years are projected to have genital infection with herpes simplex virus.
Rising R&D investments by major companies is expected to boost global market
Growing investments in R&D activities by key players in order to introduce novel & innovative products and bring advancements in diagnostic technologies like point-of-care testing, serological assays, and nucleic acid amplification tests, are further anticipated to create growth opportunities for the market.
- For instance, in June 2023, Linear Diagnostics, announced that they have obtained funding from the National Institute for Health and Care Research UK, for the development of 20-minute sexually transmitted disease test to effectively diagnose Chlamydia and gonorrhoea.
Restraining Factors
High cost of advanced diagnostic devices and limited awareness among general public hampering the market
The high costs associated with innovated diagnostic devices for STDs and lack of awareness among general population about the importance of regular STD screening and available treatment options, are factors could hamper the global market growth.
Report Segmentation
The market is primarily segmented based on product, application, technology, and region.
|
By Product |
By Application |
By Technology |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Product Insights
Consumables segment accounted for noteworthy share in 2023
The consumables segment accounted for notable share. Segment’s dominance is attributed to its increasing demand in STD diagnostics, as they are designed in such a way to provide reliable and accurate results and enable early detection of STDs. Moreover, as it is a type of multiplex test which can detect and even differentiate four common STDs at a single time, allowing health facilities to scale up their diagnostic capabilities.
The software segment is expected to grow at highest growth. This growth is due to their growing proliferation in healthcare settings because they allow for efficient management and integration of patient information while reducing manual errors and boosting efficiency.
By Application Insights
HIV testing segment held the maximum share in 2023
The HIV testing segment held the maximum revenue share. This dominance is attributable to rising prevalence of HIV diseases worldwide and growing number of government health campaigns or programs to raise awareness about the importance of HIV testing. For instance, as per our findings, more than 39 million people across the globe were living with HIV in 2022, and approx. 1.3 million people were newly affected with the disease in 2022. And, over 630,000 people died due to AIDS-related illness in the year.
By Technology Insights
Molecular diagnostics segment is expected to witness highest growth
The molecular diagnostics segment is anticipated to witness highest growth. Segment’s growth is attributed to rising use of high-throughput PCR technology for the detection of STDs due to its numerous advantages such as cost-effectiveness, accuracy, and user-friendliness. Also, the growing availability of at-home molecular testing kits for STDs allowing individuals to have tests in their homes, is further propelling segment’s growth.
The immunoassay segment led the market. This is due to its higher testing rates for STDs as compared to other technologies and growing proliferation for the regulatory approvals of new and more innovative immunoassay products for the diagnosis & care.
Regional Insights
North America region dominated the global market in 2023
The North America region dominated the global market. Region’s dominance is accelerated by rising prevalence of STD diseases and presence of technologically advanced diagnostic solutions such as nucleic acid amplification tests and point-of-care testing in the region. In addition, increasing emphasis on the adoption of early detection measures to reduce the transmission rates of STDs and growing preference for rapid and convenient testing methods, further contributes to adoption of STD diagnostics. For instance, according to the Centers for Disease Control and Prevention, about 1 in every 5 people in the US have a STI, that means around 68 million people are suffering with some kind of STIs in the country.
The Asia Pacific region is anticipated to emerge as fastest growing region. Region’s growth is accelerated by increasing number of STI cases, rapid growth in younger population who are more prone to such diseases, and robust presence of favorable government initiatives promoting the importance of early detection & diagnosis of STDs. For instance, according to our findings, over 6% of total adult population in India are affected with sexually transmitted infections.
Key Market Players & Competitive Insights
Regulatory approvals and new product development to drive market competition
The STD diagnostics market is modertaly competitive in nature with the robust presence of global and regional players consolidating for their position. Companies are competing on various factors such as improving reliability and accuracy of their diagnostic tests, compliance with regulatory standards, offering cost-effective solutions, gaining approvals from health authorities, and adoption of innovative diagnostic technologies.
Some of the major players operating in the global market include:
- Abbott Laboratories (US)
- Becton, Dickinson, and Company (US)
- bioMerieux SA (France)
- Bio-Rad Laboratories (US)
- Danaher Corporation (US)
- DiaSorin S.p.A. (Italy)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Grifols S.A. (Spain)
- Hologic Inc. (US)
- QIAGEN (Netherlands)
- Quidel Corporation (US)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare (Germany)
- Thermo Fisher Scientific (US)
Recent Developments in the Industry
- In April 2023, Jiangsu Bioperfectus Technologies announced about the CE marking for its new product called “Herpes Simplex Virus Type I/II Real Time PCR Kit”. The newly developed kit provides a STD total PCR solution especially for the early detection of sexually transmitted diseases.
- In August 2023, iHealth Labs Inc. announced the release of its new Home Collection Kit, that is specially designed for HIV and syphilis testing. The new solution is FDA-approved and enable everybody with age of 18 or over to collect blood sample for testing HIV I, II, and P24 antigen.
Report Coverage & Market Sales Outlook
The STD diagnostics market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed market analysis while focusing on various key aspects such as competitive analysis, product, application, technology, and their futuristic growth opportunities.
STD Diagnostics Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 10.81 billion |
|
Revenue forecast in 2032 |
USD 19.63 billion |
|
CAGR |
7.7% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments covered |
|
|
Regional scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
Download Sample Report
Want to check out the STD Diagnostics Market report before buying it? Then, our sample report has got you covered. It includes key market data points, ranging from trend analyses to industry estimates and forecasts. See for yourself by downloading the sample report.
Browse Our Top Selling Reports
Hydrogen Hubs Market Size, Share 2024 Research Report
Therapeutic Hypothermia Systems Market Size, Share 2024 Research Report
Digestive Health Supplements Market Size, Share 2024 Research Report
Europe Digestive Health Supplements Market Size, Share 2024 Research Report
Lidocaine Hydrochloride Market Size, Share 2024 Research Report
FAQ's
key companies in STD Diagnostics Market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Roche Diagnostics
STD diagnostics market exhibiting the CAGR of 7.7% during the forecast period.
The STD Diagnostics Market report covering key segments are product, application, technology, and region.
key driving factors in STD Diagnostics Market are Increasing incidences of STDs worldwide to drive market’s growth
The global STD diagnostics market size is expected to reach USD 19.63 billion by 2032
© 2024 Polaris Market Research and Consulting. All rights reserved
